|
|
||||||||
REVIEW |
Departments of Pathology,
1 Obstetrics and Gynecology and
2 Surgical Oncology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan
(Requests for offprints should be addressed to H Sasano; Email: hsasano{at}patholo2.med.tohoku.ac.jp)
It is well known that sex steroids are involved in the growth of breast cancers, and the great majority of breast carcinomas express estrogen (ER), progesterone (PR), and androgen (AR) receptors. In particular, recent studies have demonstrated that estrogens and androgens are locally produced in breast carcinoma tissues, and total blockade of in situ estrogen production potentially leads to an improvement in prognosis of breast cancer patients. Therefore, it is important to obtain a better understanding of sex steroid-producing enzymes in breast carcinoma tissues. In this review, we summarize recent studies on the expression and regulation of enzymes related to intratumoral production of estrogens (aromatase, 17ß-hydroxysteroid dehydrogenase type 1 (17ßHSD1), and steroid sulfatase (STS) etc) and androgens (17ßHSD5 and 5
-reductase) in human breast carcinoma tissues, and discuss the biological and/or clinical significance of these enzymes. The cellular localization of aromatase in breast carcinoma tissues still remains controversial. Therefore, we examined localization of aromatase mRNA in breast carcinoma tissues by laser capture microdissection/real time-polymerase chain reaction. Aromatase mRNA expression was detected in both carcinoma and intratumoral stromal cells, and the expression level of aromatase mRNA was higher in intratumoral stromal cells than in carcinoma cells in the cases examined. We also examined an association among the immunoreactivity of enzymes related to intratumoral estrogen production and ERs in breast carcinoma tissues, but no significant association was detected. Therefore, the enzymes responsible for the intratumoral production of estrogen may not always be the same among breast cancer patients, and not only aromatase but also other enzymes such as STS and 17ßHSD1 may have important therapeutic potential as targets for endocrine therapy in breast cancer patients.
This article has been cited by other articles:
![]() |
H. Odawara, T. Iwasaki, J. Horiguchi, N. Rokutanda, K. Hirooka, W. Miyazaki, Y. Koibuchi, N. Shimokawa, Y. Iino, I. Takeyoshi, et al. Activation of Aromatase Expression by Retinoic Acid Receptor-related Orphan Receptor (ROR) {alpha} in Breast Cancer Cells: IDENTIFICATION OF A NOVEL ROR RESPONSE ELEMENT J. Biol. Chem., June 26, 2009; 284(26): 17711 - 17719. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nagasaki, T. Suzuki, Y. Miki, J.-i. Akahira, K. Kitada, T. Ishida, H. Handa, N. Ohuchi, and H. Sasano 17{beta}-Hydroxysteroid Dehydrogenase Type 12 in Human Breast Carcinoma: A Prognostic Factor via Potential Regulation of Fatty Acid Synthesis Cancer Res., February 15, 2009; 69(4): 1392 - 1399. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Geisler, H. Helle, D. Ekse, N. K. Duong, D. B. Evans, Y. Nordbo, T. Aas, and P. E. Lonning Letrozole is Superior to Anastrozole in Suppressing Breast Cancer Tissue and Plasma Estrogen Levels Clin. Cancer Res., October 1, 2008; 14(19): 6330 - 6335. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Falk, E. Gentzschein, F. Z. Stanczyk, L. A. Brinton, M. Garcia-Closas, O. B. Ioffe, and M. E. Sherman Measurement of Sex Steroid Hormones in Breast Adipocytes: Methods and Implications Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 1891 - 1895. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Niikawa, T. Suzuki, Y. Miki, S. Suzuki, S. Nagasaki, J. Akahira, S. Honma, D. B. Evans, S.-i. Hayashi, T. Kondo, et al. Intratumoral Estrogens and Estrogen Receptors in Human Non-Small Cell Lung Carcinoma Clin. Cancer Res., July 15, 2008; 14(14): 4417 - 4426. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shibuya, T. Suzuki, Y. Miki, K. Yoshida, T. Moriya, K. Ono, J.-i. Akahira, T. Ishida, H. Hirakawa, D. B Evans, et al. Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast Endocr. Relat. Cancer, March 1, 2008; 15(1): 113 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hudelist, K. Czerwenka, J. Keckstein, C. Haas, A. Fink-Retter, D. Gschwantler-Kaulich, E. Kubista, and C.F. Singer Expression of Aromatase and Estrogen Sulfotransferase in Eutopic and Ectopic Endometrium: Evidence for Unbalanced Estradiol Production in Endometriosis Reproductive Sciences, December 1, 2007; 14(8): 798 - 805. [Abstract] [PDF] |
||||
![]() |
L. Vona-Davis and D. P Rose Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression Endocr. Relat. Cancer, June 1, 2007; 14(2): 189 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suzuki, A. Inoue, Y. Miki, T. Moriya, J.-i. Akahira, T. Ishida, H. Hirakawa, Y. Yamaguchi, S.-i. Hayashi, and H. Sasano Early growth responsive gene 3 in human breast carcinoma: a regulator of estrogen-meditated invasion and a potent prognostic factor Endocr. Relat. Cancer, June 1, 2007; 14(2): 279 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Miki, T. Suzuki, C. Tazawa, Y. Yamaguchi, K. Kitada, S. Honma, T. Moriya, H. Hirakawa, D. B. Evans, S.-i. Hayashi, et al. Aromatase Localization in Human Breast Cancer Tissues: Possible Interactions between Intratumoral Stromal and Parenchymal Cells Cancer Res., April 15, 2007; 67(8): 3945 - 3954. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rice and S. A Whitehead Phytoestrogens and breast cancer -promoters or protectors? Endocr. Relat. Cancer, December 1, 2006; 13(4): 995 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Jansson, C. Gunnarsson, M. Cohen, T. Sivik, and O. Stal 17{beta}-Hydroxysteroid Dehydrogenase 14 Affects Estradiol Levels in Breast Cancer Cells and Is a Prognostic Marker in Estrogen Receptor-Positive Breast Cancer Cancer Res., December 1, 2006; 66(23): 11471 - 11477. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Perez-Palacios, R. Santillan, R. Garcia-Becerra, E. Borja-Cacho, F. Larrea, P. Damian-Matsumura, L. Gonzalez, and A. E Lemus Enhanced formation of non-phenolic androgen metabolites with intrinsic oestrogen-like gene transactivation potency in human breast cancer cells: a distinctive metabolic pattern. J. Endocrinol., September 1, 2006; 190(3): 805 - 818. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |